Atlas Trials

A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer

Clinical trial NCT00482014 · COMPLETED

Trial details

NCT number
NCT00482014
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer
Start date
2007-05-01
Primary completion
2011-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.